InVitria is excited to participate in BioProcess International in Boston from September 23rd to 26th, 2024! Reach out to see how our technology enhances biomanufacturing performance in vaccines as well as cell and gene therapy. Meet Jacob Weber, Elliott Renft, and Jake Hanks at #BPI2024 to drive innovation together! #BPIConf #CellTherapy #GeneTherapy #Biomanufacturing
InVitria, Inc.
生物技术研究
Performance. Defined. Animal Free Components: Cell & Gene Therapy, Vaccines, Regenerative Medicines & Biopharmaceuticals
关于我们
InVitria develops, manufactures, and markets recombinant, scalable and sustainable products that improve manufacturing and formulation for cell and gene therapy, vaccines, biopharmaceuticals, CAR T cell therapy, stem cells, medical devices, and regenerative medicines.
- 网站
-
https://www.invitria.com
InVitria, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Biotech Centers
- 类型
- 私人持股
- 创立
- 2008
- 领域
- animal component-free、stem cell、T Cells、VERO Cells、tissue preservation、mammalian cells、vaccines、cell therapy、gene therapy、cell culture media、formulation、excipient、cell culture media、Biotechnology 、biology、technology、product development 、healthcare、research、science和colorado
地点
InVitria, Inc.员工
动态
-
InVitria is attending #CPHI in Milan, showcasing our commitment to revolutionizing biomanufacturing and formulation by replacing animal-derived components. Our innovative, animal-free solutions drive efficiency, safety, and consistency in life sciences, supporting the future of sustainable bioprocessing. ?????? Connect with Vinay Vinay Murtadak, Ph.D. & Marcus Curl at CPHI to discuss how we can help transform your biomanufacturing process with cutting-edge, animal-free components. Join the revolution in biomanufacturing today! Connect with our team at CPHI. #InVitria #Biomanufacturing #SustainableScience #AnimalFree #CPHI2024
-
-
At the Cell & Gene Meeting on the Mesa, Jeff Zurawski, PhD, Associate Director of BioProcess Development at DiscGenics, will present "Development of a Phase III Allogeneic Cell Therapy Manufacturing Process." His talk highlights key products from InVitria, Inc. that are instrumental in advancing allogeneic cell therapy. Be sure to attend on October 8th at 2:30 pm and learn how these innovative solutions are shaping the future of cell therapy manufacturing. Learn more about InVitria, Inc. at www.invitria.com #CellTherapy #GeneTherapy #InVitria #Bioprocessing #LifeSciences #ARMAllianceforRegenerativeMedicine
-
-
? ?? That time of the year! InVitria, Inc.'s team is gearing up for #MeetingontheMesa2024 in Phoenix! Stay tuned for exciting announcements in the coming days... Scott Deeter, Colin Odishoo, Jake Hanks, and Elliott Renft will be attending. Connect with us via the portal to schedule a meeting! Learn about replacing animal and human components from your process: https://invitria.com/ #MeetingOnTheMesa #MoM2024 #ARMAllianceforRegenerativeMedicine #CellandGeneTherapy
-
-
We are showcasing the performance advantage of Optibumin and ITSE+A for biomanufacturing and formulation at #BPI2024 in Boston. If you are seeking reliable and scalable chemically defined components that come with the strongest referrals from scientific experts in vaccines and cell & gene therapy, reach out to our team via the partnering App. See you there!
-
-
InVitria, Inc.'s Mark Stathos, Ph.D., Jake Hanks, & Elliott Renft will be attending CAR-TCR this week in Boston, MA. Mark Stathos, Ph.D. will be presenting a poster on Cryopreservation of iPSC-Derived T/NK Cells - Don't miss it! #CARTCR #CellTherapy #CMC #BloodFREE #Recombinant #Cryopreservation
-
-
Learn cryopreservation techniques to improve NK and T cell viability. Andrew Hamann, PhD is presenting at #ISCTEurope2024. More below....
???? Advancing Cell Preservation Techniques! I'll be presenting tomorrow at #ISCT Europe. Join me at poster 75 to explore our latest research: "Cryoprotectant additives, including rHSA, improve iNK and iT cell health and viability during cryopreservation." This study marks a significant step forward in cryopreservation. We've demonstrated that adding our recombinant human serum albumin (rHSA) along with other cryoprotectants can substantially improve the health and viability of iNK and iT cells during freezing/thawing. Key Insights: *rHSA as a Game-Changer: It enhances cell health significantly while avoiding the risks associated with human-derived albumin. Synergistic Effects: Our findings suggest that using a combination of cryoprotectants yields even better outcomes, paving the way for new research and applications. Looking forward to discussing these exciting developments with you!
-
-
We will be in #Gothenburg, Sweden for #ISCTEUROPE2024 hosted by ISCT, International Society for Cell & Gene Therapy. Learn about the advantages of using sustainably produced recombinant albumin for cryopreservation and to maintain cell viability and product potency. Reach out to Marcus Curl or Andrew Hamann, PhD to learn more. #animalfree #sustainable
-
-
Join our team (Andrew Hamann, PhD & Marcus Curl) at #ISCTEUROPE2024 in #Gothenburg to share the journey to a sustainable future for biomanufacturing.
VP, Product Applications at InVitria | Expertise in Blood-Free Manufacturing for Advanced Therapies | Innovating in Gene Therapy, Cell Therapy, and Vaccine Production
??I'm excited to share that InVitria will be attending the ISCT Europe 2024 Regional Meeting in Gothenburg, Sweden, next week! We’re gearing up to introduce our latest innovations aimed at replacing human and animal-derived components in cell and gene therapy manufacturing. ?? I’ll be joining Andrew Hamann, PhD, Product Applications Scientist, to present new data on cryopreservation and offer a sneak peek at our upcoming product launch. Don’t miss out—book a meeting with us to learn more. Looking forward to seeing you there! #ISCT2024 #Gothenburg #CellTherapy #GeneTherapy #Biomanufacturing #InVitria #AnimalFree #Innovation
-
-
#BioprocessingSummit is in full swing for InVitria, Inc.! Substitution alert - Colin Odishoo is wrapping up a successful Mon/Tue. Elliott Renft will be attending today/tomorrow! Are you trying to mitigate the risks associated with animal & human components used for biomanufacturing? Human AB Serum or HSA giving you a headache? Recombinant, Scalable, and Sustainable - you'll be in good hands. #Celltherapy #Genetherapy #animalfree #bioprocessing #biomanufacturing #CGT #sustainability
-